Diego Serrano

Universidad de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Paola Jablonska

Clinica Universidad de Navarra

SPAIN

View details

Javier Aristu

Associate Professor

Universidad de Navarra

SPAIN

View details

Alfonso Calvo

Universidad de Navarra

SPAIN

View details

Ruben Pio

Professor

Universidad de Navarra

SPAIN

View details

Graziella Bosco

University of Cologne

GERMANY

View details

Ramón Robledano Soldevilla

Clinica Universidad de Navarra

SPAIN

View details

Cristina Bértolo

Universidad de Navarra

SPAIN

View details

Eva Maria Garrido Martin

Profesor Ayudante Doctor Biología Celular

SPAIN

View details

Enrique Conde-Gallastegi

Public University of Navarre

SPAIN

View details

Daniel Ajona

Assistant Professor

Universidad de Navarra

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Diego Serrano

Research Interests

Explore related searches

Contact this professor

Articles (10)

Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases

Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer

YES1 Is a Druggable Oncogenic Target in SCLC.

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells.

Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists

Two alternative cell line models for the study of multiorganic metastasis and immunotherapy in Lung Squamous Cell Carcinoma.

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer

Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies

Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy

Collaborators (10)

Paola Jablonska

Javier Aristu

Alfonso Calvo

Ruben Pio

Graziella Bosco

Ramón Robledano Soldevilla

Cristina Bértolo

Eva Maria Garrido Martin

Enrique Conde-Gallastegi

Daniel Ajona

Make your next move.